Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the signaling of interleukin (IL)-31.

It is not known what ingredients in facial products may predispose individuals to perioral dermatitis. It has been suggested that fluoride-containing compounds may be implicated in the disease ...

"For a long time, those with atopic dermatitis, like Greg Blankenship, had to be treated with steroids," Muennich said. "It's pretty chronic, no great cure, but we do have newer treatments." ...

"This simple microbial compound could work as a standalone therapy, or in synergy with existing treatments," Le Poole said. In 2022, the FDA approved the first re-pigmentation therapy for vitiligo ...

Your protein needs change as you get older. Here’s how much you should be eating at every age Canada announces retaliatory tariffs on long-time ally US Here is the average 401(k) balance of ...

According to N12, hair stylists and manicurists arrived at the hospital to provide beauty treatments for the women, Liri Albag, Naama Levy, Karina Ariev, and Daniella Gilboa. Medical professionals ...

highlights the Korean 15-step stem cell scalp treatment as a key beauty trend for 2025. This 60-90 minute procedure addresses scalp issues like dandruff, psoriasis, and seborrheic dermatitis ...

Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a ...

Combining baricitinib with narrowband UV-B therapy could be an effective treatment for those with severe, active vitiligo, according to a new study published today in JAMA Dermatology. Vitiligo is a ...